SARS-CoV-2
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
August, 2020
C19 Treatment Decision Tree by Dr. Peter A. McCullough, MD, MPH
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
Herd Immunity Thresholds for SARS-CoV-2 Estimated from Unfolding Epidemics
SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis
SARS-CoV-2 and the Role of Orofecal Transmission
July, 2020
Verdict
Various observational and mechanistic evidence presented throughout this evidence brief, support the hypothesis that SARS-CoV-2 can infect and be shed from the human gastrointestinal tract.
Policy
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
Spread of SARS-CoV-2 in the Icelandic Population
June, 2020
CONCLUSIONS
In a population-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infection than adolescents or adults and males. The proportion of infected persons identified through population screening did not change substantially during the screening period, which was consistent with a beneficial effect of containment efforts.